HealthEquity HQY Ratios & Valuation
| TTM Q1 '27 | TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70.7%+5.2pp | 69.5%+4.7pp | 67.7%+2.4pp | 66.4%+1.5pp | 65.5%+2.1pp | |
| Operating margin | 25.6%+9.2pp | 24.6%+11.0pp | 22.7%+8.9pp | 18.5%+3.0pp | 16.4%+3.3pp | |
| Net margin | 17.3%+7.5pp | 16.4%+8.3pp | 14.9%+6.5pp | 11.5%+1.9pp | 9.8%+2.1pp | |
| EBITDA margin | 37.1%+7.7pp | 36.3%+9.3pp | 34.8%+6.9pp | 30.9%+1.0pp | 29.4%+1.7pp | |
| Free cash flow margin | 36.5%+9.3pp | 34.7%+6.5pp | 32%+2.5pp | 28.8%+1.0pp | 27.2%+0.9pp | |
| Returns | ||||||
| Return on equity | 11.1%+5.3pp | 10.2%+5.5pp | 9%+4.3pp | 6.8%+1.6pp | 5.8%+1.8pp | |
| Return on assets | 6.9%+3.2pp | 6.3%+3.4pp | 5.6%+2.6pp | 4.2%+1.0pp | 3.7%+1.1pp | |
| Return on invested capital | 9.3%+3.7pp | 8.7%+3.8pp | 7.9%+3.1pp | 6.3%+1.3pp | 5.6%+1.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.4×-0.6× | 3.3×+0.2× | 4.1×+0.9× | 4.2×+0.1× | 4.1×-0.3× | |
| Quick ratio | 3.4×-0.6× | 3.3×+0.2× | 4.1×+0.9× | 4.2×+0.1× | 4.1×-0.3× | |
| Cash ratio | 2×-0.5× | 2×+0.1× | 2.6×+0.5× | 2.6×-0.1× | 2.5×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×0.0× | 0.5×0.0× | 0.5×-0.1× | 0.5×0.0× | 0.5×+0.1× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Net debt / EBITDA | 1.4×-0.8× | 1.4×-1.1× | 1.6×-0.9× | 1.9×-0.6× | 2.2×-0.3× | |
| Interest coverage | 6.2×+3.0× | 5.6×+3.0× | 5×+2.3× | 3.7×+0.6× | 3.2×+0.6× | |
| Per Share | ||||||
| Book value per share | $24.09+0.3% | $24.09+1.2% | $24.54+2.4% | $24.46+0.5% | $24.02+1.1% | |
| Valuation | ||||||
| Market capitalization | $6.93B-6.7% | $7.32B-23.5% | $8.15B+9.7% | $8.39B+23.6% | $7.42B+9.4% | |
| Enterprise value | $7.65B-7.2% | $8B-22.9% | $8.87B+7.6% | $9.14B+20.0% | $8.24B+9.7% | |
| Price / earnings | 30×-30.9× | 34×-64.9× | 42.5×-34.3× | 57.5×-6.7× | 60.9×-23.4× | |
| Price / sales | 5.2×-0.8× | 5.6×-2.4× | 6.3×-0.1× | 6.6×+0.4× | 6×-0.5× | |
| Price / book | 3.4×-0.1× | 3.5×-1.1× | 3.8×+0.3× | 3.9×+0.8× | 3.5×+0.3× | |
| EV / EBITDA | 15.4×-7.1× | 16.8×-15.2× | 19.8×-6.0× | 23.3×+0.2× | 22.5×-3.5× | |
| EV / sales | 5.7×-0.9× | 6.1×-2.6× | 6.9×-0.3× | 7.2×+0.3× | 6.6×-0.6× | |
| Free cash flow yield | 7%+2.5pp | 6.2%+2.7pp | 5.1%+0.5pp | 4.4%-0.1pp | 4.5%+0.5pp | |
| Earnings yield | 3.3%+1.7pp | 2.9%+1.9pp | 2.4%+1.1pp | 1.7%+0.2pp | 1.6%+0.5pp | |
| PEG ratio | 0.3×-0.8× | 0.3×— | 0.4×— | 1.5×— | 1.2×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are HealthEquity's profit margins?
- HealthEquity (HQY) runs a 70.7% gross margin and a 25.6% operating margin, with a 17.3% net margin.
- Where do HealthEquity's ratios come from?
- Every ratio is computed from HealthEquity's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
